Mesenchymal stem cells, aging and regenerative medicine. 2012

Chiara Raggi, and Anna C Berardi
Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, USA.

Tissue maintenance and regeneration is dependent on stem cells and increasing evidence has shown to decline with age. Stem cell based-aging is thought to influence therapeutic efficacy. Mesenchymal stromal cells (MSCs) are involved in tissue regeneration. Here, we discuss the effects of age-related changes on MSC properties considering their possible use in research or regenerative medicine.

UI MeSH Term Description Entries

Related Publications

Chiara Raggi, and Anna C Berardi
December 2018, Regenerative therapy,
Chiara Raggi, and Anna C Berardi
January 2018, Stem cells international,
Chiara Raggi, and Anna C Berardi
January 2020, Frontiers in cell and developmental biology,
Chiara Raggi, and Anna C Berardi
August 2019, Cells,
Chiara Raggi, and Anna C Berardi
January 2018, Advances in experimental medicine and biology,
Chiara Raggi, and Anna C Berardi
January 2022, Advances in experimental medicine and biology,
Chiara Raggi, and Anna C Berardi
January 2010, Recent patents on biotechnology,
Chiara Raggi, and Anna C Berardi
April 2013, Development, growth & differentiation,
Chiara Raggi, and Anna C Berardi
January 2019, Journal of stem cells & regenerative medicine,
Chiara Raggi, and Anna C Berardi
January 2017, Bio-medical materials and engineering,
Copied contents to your clipboard!